Evidence map›Paper›PMID 34410965›Full record

ArticleIn vivo (Athens, Greece)

Neutrophil Gelatinase-associated Lipocalin Predicts Post-traumatic Acute Kidney Injury in Severely Injured Patients.

Katharina Leditzke, Maximilian Eberhard Hermann Wagner, Claudia Neunaber, Jan-Dierk Clausen, Marcel Winkelmann

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Bimodal distribution of trauma-related acute kidney injury (TrAKI): A clinical review.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katharina LeditzkeTrauma Department, Hannover Medical School, Hannover, Germany.
Maximilian Eberhard Hermann WagnerDepartment of Maxillofacial Surgery, University of Zürich, Zürich, Switzerland.
Claudia NeunaberTrauma Department, Hannover Medical School, Hannover, Germany.
Jan-Dierk ClausenTrauma Department, Hannover Medical School, Hannover, Germany.
Marcel WinkelmannTrauma Department, Hannover Medical School, Hannover, Germany; winkelmann.marcel@mh-hannover.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly detection of acute kidney injury (AKI) is crucial in the management of multiple-organ dysfunction syndrome in severely injured patients. Standard laboratory parameters usually increase with temporal delay. Therefore, we evaluated neutrophil gelatinase-associated lipocalin (NGAL) as an early marker for acute kidney injury. PATIENTS AND

methodsWe retrospectively evaluated patients admitted to a level 1 trauma center. We collected clinicodemographic data and measured kidney-related factors and plasma cytokines.

resultsA total of 39 patients were included. Patients with AKI had significantly higher levels not only of serum creatinine and urea, but also of NGAL (all p<0.001) than patients without AKI. The optimal NGAL cut-off value was determined to be 177 ng/ml, showing significant correlation with imminent or manifest AKI (p<0.001). Other independent markers correlated with AKI included pre-existing chronic kidney disease, use of catecholamines, and severe injury (p<0.001).

conclusionThe serum level of NGAL is feasible early predictor of AKI.

Indexed as

Acute Kidney InjuryLipocalinsAcute-Phase ProteinsBiomarkersHumansLipocalin-2Proto-Oncogene ProteinsRetrospective StudiesAcute-Phase ProteinsBiomarkersLipocalin-2LipocalinsProto-Oncogene Proteinsacute kidney failureAcute kidney injuryLCN2lipocalin 2multiple-organ dysfunction syndromemultiple-organ failuremultiple traumaneutrophil gelatinase-associated lipocalin

Identifiers

PMID34410965
PMCPMC8408701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.